2019 Surgical Oncology Symposium

2019 Surgical Oncology Symposium
Saturday, November 9, 2019 - 7:00am - 12:00pm

Join us as we discuss diagnosis and treatment options of ovarian cancer, update new concepts for DCIS and breast cancer, review algorithms for pain management that allow us to omit narcotics for post-operative pain management, and more. We’ll also review the detection and management of early rectal cancers. In addition, we will feature a live demonstration of advanced perfusion techniques.

Designed For

Physicians, Nurse Practitioners, Physician Assistants, Nurses, Fellows, Residents, Students and Other Interested Healthcare Providers

Jointly Provided By

Creighton University School of Medicine
Department of Medicine
Office of Continuing Education
CHI Health

4.25 CE hours
Remote viewing locations:
CHI Health Good Samaritan, room D/E/F
CHI Health St. Francis, room 2/3
CHI Health St. Elizabeth, Franciscan Conference Room


  • Describe the rationale and evolution of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC)
  • Review outcomes of CS+HIPEC
  • Discuss patient selection for CS+HIPEC
  • Describe DCIS and its pre-invasive cancer state
  • Review treatment options for DCIS
  • Describe the differences between DCIS and LCIS
  • Discuss the challenges in the diagnosis of ovarian cancer
  • Explain the new diagnostic assays available to the clinician in differentiating benign from malignant ovarian cysts
  • Discuss examples of new investigator-initiated targeted therapies for the treatment of chemotherapy resistant ovarian cancer
  • Review the indications for the use of veno-venous bypass to enhance the safety of selected major abdominal or retroperitoneal procedures
  • Demonstrate how the procedure is put into practice
  • Demonstrate how HIPEC is safely applied after cytoreductive surgery
  • Describe the evidence-based algorithms that allow us in many cases to avoid the use of parental or oral narcotics after major abdominal surgery
  • Review how pre-operative prescription of narcotics can interfere with post-operative pain management
  • Define goals of local excision techniques in early stage rectal cancer
  • Identify patients who may be candidates for local excision with early stage rectal cancer
  • Review surveillance guidelines and define indications for rectal resection in patients with early stage rectal cancer


7 a.m.
Registration, Continental Breakfast and Visit Exhibits

7:30 a.m.
Introduction and Management of Primary and Metastatic Peritoneal Cancers

Brian W. Loggie, MD

8 a.m.
Ductal Carcinoma In-Site (DCIS) or Pre-invasive Breast Cancer
Michael J. McNamara, MD, FACS

9 a.m.
The Diagnosis and Treatment of Ovarian Cancer: From the Research Bench to the Patient Bedside

Robin Farias-Eisner, MD, PhD

10 a.m.
Working Break

Advanced Perfusion Techniques: Veno-Venous Bypass and HIPEC Perfusion
Noelle Meyer, MA, CCP, LP
Hugh Gass, CCP, LP, CPBMT

10:15 a.m.
Enhanced Recovery After Surgery
Mark Reisbig, MD

11 a.m.
Management of Early Stage Rectal Cancer
Devi Mukkai Krishnamurty, MBBS

12 p.m.
Closing Remarks
Brian W. Loggie, MD

In Memory of Michael David Smith

February 17, 1944–May 13, 2019

This symposium has been made possible by the estate of Michael David Smith. Michael was a former patient of Dr. Brian W. Loggie and a committed supporter of philanthropic initiatives. In 2004, Michael was diagnosed with a rare appendix disease called pseudomyxoma peritonei. He battled it with courage and strength, even reaching out to others suffering from this little-known disease, offering knowledge and support.
At the end of his life when asked what he loved to do most, Michael answered, “Mow my lawn and take long walks.” A devoted father and grandfather, Michael was a man who enjoyed a simple life. He had a vibrant and welcoming personality, lighting up the room with every entrance. He made everyone feel special and made sure they knew how much he appreciated them. His loving heart brought joy and smiles to all who were blessed to know him. He is deeply missed.

Education Credit

Category 1
Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit(s) TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.

Nurse CE
Creighton University Health Sciences Continuing Education designates this activity for 4.25 contact hour(s) for nurses.  Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education (HSCE) and CHI Health.  Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


$10 for live and remote viewing

CHI Health Creighton University Medical Center-Bergan Mercy
7710 Mercy Road
Room 11661 A, B, and C
Omaha, NE 68124
United States